Exagen appoints John Aballi as CEO
seekingalpha.com
finance
2022-10-17 13:17:49

Exagen (NASDAQ:XGN) has appointed John Aballi as CEO and President.
Longtime CEO and President Ron Rocca, who took the company public and built a robust growth business, is stepping down after 11 years at the helm.
Most recently, John Aballi served as SVP, General Manager, Urology & CLIA COO at Veracyte.
